V J Verwaal

Summary

Affiliation: The Netherlands Cancer Institute
Country: The Netherlands

Publications

  1. ncbi request reprint Recurrences after peritoneal carcinomatosis of colorectal origin treated by cytoreduction and hyperthermic intraperitoneal chemotherapy: location, treatment, and outcome
    Vic J Verwaal
    Department of Surgery, The Netherlands Cancer Institute and Antoni van Leeuwenhoeck Hospital, Amsterdam, The Netherlands
    Ann Surg Oncol 11:375-9. 2004
  2. pmc Specific genomic aberrations in primary colorectal cancer are associated with liver metastases
    Sjoerd C Bruin
    Division of Experimental Therapy, Department of Pathology, The Netherlands Cancer Institute Antoni van Leeuwenhoek Hospital, Plesmanlaan 121, 1066CX Amsterdam, The Netherlands
    BMC Cancer 10:662. 2010
  3. ncbi request reprint Long-term survival of peritoneal carcinomatosis of colorectal origin
    Vic J Verwaal
    Department of Surgery, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands
    Ann Surg Oncol 12:65-71. 2005
  4. doi request reprint 8-year follow-up of randomized trial: cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy in patients with peritoneal carcinomatosis of colorectal cancer
    Vic J Verwaal
    Department of Surgery, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands
    Ann Surg Oncol 15:2426-32. 2008
  5. ncbi request reprint Detection and treatment of recurrent disease after cytoreduction and HIPEC
    V J Verwaal
    Department of Surgery, The Netherlands Cancer Institute, Amsterdam
    Cancer Treat Res 134:419-24. 2007
  6. ncbi request reprint Follow-up of patients treated by cytoreduction and chemotherapy for peritoneal carcinomatosis of colorectal origin
    V J Verwaal
    Department of Surgery, The Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands
    Eur J Surg Oncol 30:280-5. 2004
  7. ncbi request reprint Toxicity of cytoreductive surgery and hyperthermic intra-peritoneal chemotherapy
    Vic J Verwaal
    Department of Surgery, The Netherlands Cancer Institute Antoni van Leeuwenhoek Hospital, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands
    J Surg Oncol 85:61-7. 2004
  8. doi request reprint Long-term results of cytoreduction and HIPEC followed by systemic chemotherapy
    Vic J Verwaal
    The Netherlands Cancer Institute Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands
    Cancer J 15:212-5. 2009
  9. ncbi request reprint Results of cytoreduction followed by HIPEC in carcinomatosis of colorectal origin
    V J Verwaal
    Department of Surgery, The Netherlands Cancer Institute, Amsterdam
    Cancer Treat Res 134:291-301. 2007
  10. ncbi request reprint Cytoreduction and HIPEC for peritoneal carcinomatosis from colorectal origin: the Amsterdam experience
    V J Verwaal
    The Netherlands Cancer Institute, Amsterdam, The Netherlands
    Acta Chir Belg 106:283-4. 2006

Collaborators

Detail Information

Publications39

  1. ncbi request reprint Recurrences after peritoneal carcinomatosis of colorectal origin treated by cytoreduction and hyperthermic intraperitoneal chemotherapy: location, treatment, and outcome
    Vic J Verwaal
    Department of Surgery, The Netherlands Cancer Institute and Antoni van Leeuwenhoeck Hospital, Amsterdam, The Netherlands
    Ann Surg Oncol 11:375-9. 2004
    ..This study evaluates the outcome of such recurrences after initial treatment by cytoreduction and HIPEC...
  2. pmc Specific genomic aberrations in primary colorectal cancer are associated with liver metastases
    Sjoerd C Bruin
    Division of Experimental Therapy, Department of Pathology, The Netherlands Cancer Institute Antoni van Leeuwenhoek Hospital, Plesmanlaan 121, 1066CX Amsterdam, The Netherlands
    BMC Cancer 10:662. 2010
    ..Patterns of genomic aberrations in primary colorectal tumors may reveal a chromosomal signature for organ specific metastases...
  3. ncbi request reprint Long-term survival of peritoneal carcinomatosis of colorectal origin
    Vic J Verwaal
    Department of Surgery, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands
    Ann Surg Oncol 12:65-71. 2005
    ..In The Netherlands Cancer Institute, this treatment has been performed since 1995. The long tradition of this treatment enabled us to study long-term survival in detail...
  4. doi request reprint 8-year follow-up of randomized trial: cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy in patients with peritoneal carcinomatosis of colorectal cancer
    Vic J Verwaal
    Department of Surgery, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands
    Ann Surg Oncol 15:2426-32. 2008
    ..This trial showed a positive result favoring the studied treatment. This trial has now been updated to a minimal follow-up of 6 years to show long-term results...
  5. ncbi request reprint Detection and treatment of recurrent disease after cytoreduction and HIPEC
    V J Verwaal
    Department of Surgery, The Netherlands Cancer Institute, Amsterdam
    Cancer Treat Res 134:419-24. 2007
  6. ncbi request reprint Follow-up of patients treated by cytoreduction and chemotherapy for peritoneal carcinomatosis of colorectal origin
    V J Verwaal
    Department of Surgery, The Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands
    Eur J Surg Oncol 30:280-5. 2004
    ..The aim of this study was to determine the value of medical history and physical examination, tumour marker testing, and CT-scanning in the follow-up of patients treated for peritoneal carcinomatosis of colorectal origin...
  7. ncbi request reprint Toxicity of cytoreductive surgery and hyperthermic intra-peritoneal chemotherapy
    Vic J Verwaal
    Department of Surgery, The Netherlands Cancer Institute Antoni van Leeuwenhoek Hospital, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands
    J Surg Oncol 85:61-7. 2004
    ..Cytoreduction with hyperthermic intra-peritoneal chemotherapy (HIPEC) is a treatment with a high morbidity. Optimal patients selection can possible reduce toxicity and complications...
  8. doi request reprint Long-term results of cytoreduction and HIPEC followed by systemic chemotherapy
    Vic J Verwaal
    The Netherlands Cancer Institute Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands
    Cancer J 15:212-5. 2009
    ..This treatment has been available for more than 10 years. Therefore, long-term results on survival and quality of life can now be studied. With these results, the true long-term benefits of this new management strategy can be determined...
  9. ncbi request reprint Results of cytoreduction followed by HIPEC in carcinomatosis of colorectal origin
    V J Verwaal
    Department of Surgery, The Netherlands Cancer Institute, Amsterdam
    Cancer Treat Res 134:291-301. 2007
  10. ncbi request reprint Cytoreduction and HIPEC for peritoneal carcinomatosis from colorectal origin: the Amsterdam experience
    V J Verwaal
    The Netherlands Cancer Institute, Amsterdam, The Netherlands
    Acta Chir Belg 106:283-4. 2006
  11. ncbi request reprint Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer
    Vic J Verwaal
    Department of Surgery, Netherlands Cancer Institute Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands
    J Clin Oncol 21:3737-43. 2003
    ....
  12. ncbi request reprint Predicting the survival of patients with peritoneal carcinomatosis of colorectal origin treated by aggressive cytoreduction and hyperthermic intraperitoneal chemotherapy
    V J Verwaal
    Departments of Surgery, The Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands
    Br J Surg 91:739-46. 2004
    ..Cytoreduction followed by hyperthermic intraperitoneal chemotherapy (HIPEC) is a new treatment option. Patient selection is crucial to outcome...
  13. ncbi request reprint Toxicity and mortality of cytoreduction and intraoperative hyperthermic intraperitoneal chemotherapy in pseudomyxoma peritonei--a report of 103 procedures
    R M Smeenk
    Department of Surgery, The Netherlands Cancer Institute Antoni van Leeuwenhoek Hospital, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands
    Eur J Surg Oncol 32:186-90. 2006
    ....
  14. ncbi request reprint Heat penetration in locally applied hyperthermia in the abdomen during intra-operative hyperthermic intraperitoneal chemotherapy
    S van Ruth
    Department of Surgical Oncology, The Netherlands Cancer Institute Antoni van Leeuwenhoek Hospital, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands
    Anticancer Res 23:1501-8. 2003
    ..The aim of this study was to evaluate heat penetration in the abdomen during 10 HIPEC procedures...
  15. doi request reprint Quantitative intra-operative assessment of peritoneal carcinomatosis - a comparison of three prognostic tools
    H A M Swellengrebel
    Department of Surgical Oncology, The Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands
    Eur J Surg Oncol 35:1078-84. 2009
    ..We compared the predictive power of three intra-operative assessment tools of peritoneal involvement of colorectal cancer...
  16. ncbi request reprint Preoperative computed tomography and selection of patients with colorectal peritoneal carcinomatosis for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy
    E de Bree
    Department of Surgical Oncology, Antoni van Leeuwenhoek Hospital The Netherlands Cancer Unit, Amsterdam, The Netherlands
    Eur J Surg Oncol 32:65-71. 2006
    ..We studied whether poor survivors could be identified on preoperative computed tomography (CT), in order to avoid unnecessary surgery...
  17. ncbi request reprint Cytoreductive surgery combined with intraoperative hyperthermic intrathoracic chemotherapy for stage I malignant pleural mesothelioma
    S van Ruth
    Department of Surgical Oncology, The Netherlands Cancer Institute Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands
    Ann Surg Oncol 10:176-82. 2003
    ..Cytoreductive surgery combined with intraoperative hyperthermic intrathoracic chemotherapy is used to kill residual tumor cells on the surface of the thoracic cavity while having limited systemic side effects...
  18. ncbi request reprint Appendiceal neoplasms and pseudomyxoma peritonei: a population based study
    R M Smeenk
    Department of Surgery, The Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands
    Eur J Surg Oncol 34:196-201. 2008
    ..However it is not known exactly how often these neoplasms lead to PMP. The aim of this study is to investigate the incidence of both lesions and their relation...
  19. pmc Multidisciplinary discussion and management of rectal cancer: a population-based study
    H A M Swellengrebel
    Department of Gastroenterology, The Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands
    World J Surg 35:2125-33. 2011
    ..The purpose of the present study was to evaluate the value of discussing rectal cancer patients in a multidisciplinary team (MDT)...
  20. ncbi request reprint Learning curve of combined modality treatment in peritoneal surface disease
    R M Smeenk
    Department of Surgery, Netherlands Cancer Institute Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands
    Br J Surg 94:1408-14. 2007
    ..Cytoreductive surgery with intraperitoneal chemotherapy has emerged as a new standard approach for peritoneal surface disease. This study investigated the learning curve of this combined modality treatment at a single institute...
  21. ncbi request reprint Pseudomyxoma peritonei and the urinary tract: involvement and treatment related complications
    R M Smeenk
    Department of Surgery, The Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands
    J Surg Oncol 93:20-3. 2006
    ..The aim of this study was to analyze primary and secondary involvement and treatment-related complications of the urinary tract in PMP...
  22. ncbi request reprint Conventional surgery and systemic chemotherapy for peritoneal carcinomatosis of colorectal origin: a prospective study
    A L A Bloemendaal
    Department of Surgery, The Netherlands Cancer Institute Antoni van Leeuwenhoek Hospital, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands
    Eur J Surg Oncol 31:1145-51. 2005
    ..To report the results of standard therapy for peritoneal carcinomatosis of colorectal origin, which consists of conventional surgery and systemic chemotherapy...
  23. ncbi request reprint Pharmacokinetics of intraperitoneal mitomycin C
    S van Ruth
    Department of Surgical Oncology, Netherlands Cancer Institute Antoni van Leeuwenhoek Hospital, Plesmanlaan 121, Amsterdam 1066 CX, The Netherlands
    Surg Oncol Clin N Am 12:771-80. 2003
    ..Comparative analyses on MMC pharmacokinetics are difficult to perform because the diversity of treatment techniques. We recommend administration of MMC, divided in three drug additions, based on BSA...
  24. ncbi request reprint Pseudomyxoma peritonei: a review of 62 cases
    S van Ruth
    Department of Surgical Oncology, The Netherlands Cancer Institute Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands
    Eur J Surg Oncol 29:682-8. 2003
    ..Pseudomyxoma peritonei (PMP) is a rare disease characterized by the abundance of mucus in the abdomen without extra-peritoneal growth...
  25. ncbi request reprint Prognostic value of baseline and serial carcinoembryonic antigen and carbohydrate antigen 19.9 measurements in patients with pseudomyxoma peritonei treated with cytoreduction and hyperthermic intraperitoneal chemotherapy
    S van Ruth
    Department of Surgical Oncology, The Netherlands Cancer Institute Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands
    Ann Surg Oncol 9:961-7. 2002
    ..9 (CA19.9) measurements in patients with pseudomyxoma peritonei treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC)...
  26. ncbi request reprint Pseudomyxoma peritonei
    R M Smeenk
    Department of Surgery, The Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands
    Cancer Treat Rev 33:138-45. 2007
    ..This approach is currently carried out in many centers throughout the world with promising results and seems to win ground as the standard treatment approach...
  27. pmc Molecular alterations associated with liver metastases development in colorectal cancer patients
    S C Bruin
    Department of Surgery, Division of Experimental Therapy, The Netherlands Cancer Institute Antoni van Leeuwenhoek Hospital, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands
    Br J Cancer 105:281-7. 2011
    ..We evaluated whether chromosomal aberrations, mutations in the PI(3)K signalling pathway and the CpG-island methylator phenotype (CIMP) in primary colorectal tumours can predict liver metastases...
  28. doi request reprint Toxicity and complications of preoperative chemoradiotherapy for locally advanced rectal cancer
    H A M Swellengrebel
    Department of Gastroenterology and Hepatology, Netherlands Cancer Institute Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands
    Br J Surg 98:418-26. 2011
    ..In this study acute toxicity and surgical complications were evaluated in patients with locally advanced rectal cancer following total mesorectal excision (TME) after preoperative chemoradiotherapy (CRT) with capecitabine...
  29. doi request reprint Effect of preservation of the right gastro-epiploic artery on delayed gastric emptying after cytoreductive surgery and HIPEC: a randomized clinical trial
    D J Evers
    Department of Surgery, The Netherlands Cancer Institute NKI AvL, Amsterdam, The Netherlands
    Eur J Surg Oncol 37:162-7. 2011
    ..The aim of this study was to investigate if preservation of the right gastro-epiploic artery (GEA) during standard omentectomy would have a positive effect on gastric emptying after CRS-HIPEC...
  30. ncbi request reprint Lessons learnt from clinical trials in peritoneal surface oncology: colorectal carcinomatosis
    Frans A N Zoetmulder
    The Netherlands Cancer Institute, Antoni van Leeuwenhoek Ziekenhuis, Amsterdam
    Recent Results Cancer Res 169:99-103. 2007
  31. ncbi request reprint Progression of pseudomyxoma peritonei after combined modality treatment: management and outcome
    Robert M Smeenk
    Department of Surgical Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands
    Ann Surg Oncol 14:493-9. 2007
    ..The aim of this study was to determine the patterns of failure in patients who underwent such a procedure and to evaluate management and outcome of progressive disease...
  32. ncbi request reprint Hyperthermic intraperitoneal chemotherapy added to the treatment of ovarian cancer. A review of achieved results and complications
    E Dovern
    Department of Surgery, Catharina Hospital Eindhoven, The Netherlands
    Eur J Gynaecol Oncol 31:256-61. 2010
    ..More recently, the modality of intraperitoneal administration of chemotherapy under hyperthermic conditions (HIPEC) has been added. This review surveys the results of HIPEC added to CRS in ovarian cancer...
  33. ncbi request reprint Pharmacokinetics of doxorubicin and cisplatin used in intraoperative hyperthermic intrathoracic chemotherapy after cytoreductive surgery for malignant pleural mesothelioma and pleural thymoma
    S van Ruth
    Department of Surgical Oncology, The Netherlands Cancer Institute Antoni van Leeuwenhoek Hospital, Amsterdam
    Anticancer Drugs 14:57-65. 2003
    ..We conclude that HITHOC with doxorubicin and cisplatin is relatively a safe procedure with the advantage of high intrathoracic cytostatic drug concentrations, while having limited systemic side effects...
  34. doi request reprint Indication for oophorectomy during cytoreduction for intraperitoneal metastatic spread of colorectal or appendiceal origin
    D J Evers
    Department of Surgery, The Netherlands Cancer Institute, Amsterdam 1066 CX, The Netherlands
    Br J Surg 98:287-92. 2011
    ..The incidence of ovarian metastases at the time of peritoneal carcinomatosis, and the influence of such metastases on survival after cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC), are unknown...
  35. pmc Survival analysis of pseudomyxoma peritonei patients treated by cytoreductive surgery and hyperthermic intraperitoneal chemotherapy
    Robert M Smeenk
    Department of Surgery, The Netherlands Cancer Institute Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands
    Ann Surg 245:104-9. 2007
    ..To evaluate the survival of patients with pseudomyxoma peritonei (PMP) treated by cytoreductive surgery and intraoperative hyperthermic intraperitoneal chemotherapy (HIPEC), and to identify factors with prognostic value...
  36. ncbi request reprint Population pharmacokinetics and pharmacodynamics of mitomycin during intraoperative hyperthermic intraperitoneal chemotherapy
    Serge van Ruth
    Department of Surgical Oncology, The Netherlands Cancer Institute Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands
    Clin Pharmacokinet 43:131-43. 2004
    ..During recent years, cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy (HIPEC) with mitomycin has been used for various malignancies...
  37. pmc A trial of consent procedures for future research with clinically derived biological samples
    E Vermeulen
    The Netherlands Cancer Institute, Plesmanlaan 121, Amsterdam 1066 CX, The Netherlands
    Br J Cancer 101:1505-12. 2009
    ..The aims of this study were to determine which consent procedure patients prefer for use of stored tissue for research purposes and what the effects of consent procedures on actual consenting behaviour are...
  38. ncbi request reprint Indication for oophorectomy during cytoreduction for intraperitoneal metastatic spread of colorectal or appendiceal origin
    D J Evers
    Department of Surgery, The Netherlands Cancer Institute, Amsterdam 1066 CX, The Netherlands
    Br J Surg 98:287-92. 2011
    ..The incidence of ovarian metastases at the time of peritoneal carcinomatosis, and the influence of such metastases on survival after cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC), are unknown...
  39. doi request reprint The eligibility for local-regional treatment of peritoneal surface malignancy
    Vic J Verwaal
    Department of Surgery, The Netherlands Cancer Institute, Amsterdam, The Netherlands
    J Surg Oncol 98:220-3. 2008
    ..General conflicting points concerning the eligibility to the local-regional therapy were discussed and voted...